loadpatents
Patent applications and USPTO patent grants for Cobbold; Mark.The latest application filed is for "target peptides for cancer therapy and diagnostics".
Patent | Date |
---|---|
Target Peptides For Cancer Therapy And Diagnostics App 20220265791 - Hunt; Donald F. ;   et al. | 2022-08-25 |
Transposon-based Modifications Of Immune Cells App 20220170044 - Cobbold; Mark ;   et al. | 2022-06-02 |
Class I Mhc Phosphopeptides For Cancer Immunotherapy And Diagnosis App 20220041655 - HUNT; Donald F. ;   et al. | 2022-02-10 |
Re-directed immunotherapy Grant 11,236,131 - Cobbold , et al. February 1, 2 | 2022-02-01 |
Antibody Tumor-targeting Assembly Complexes App 20210269547 - COBBOLD; Mark ;   et al. | 2021-09-02 |
Methods Of Modulating Antigenicity To Enhance Recognition By T-cells App 20210220337 - COBBOLD; Mark ;   et al. | 2021-07-22 |
Target Peptides For Colorectal Cancer Therapy And Diagnostics App 20210154279 - Hunt; Donald F. ;   et al. | 2021-05-27 |
Modified T Cells And Methods Of Their Use App 20210137978 - MAUS; Marcela V. ;   et al. | 2021-05-13 |
Target peptides for colorectal cancer therapy and diagnostics Grant 10,682,399 - Hunt , et al. | 2020-06-16 |
Targeting Moiety Peptide Epitope Complexes Having a Plurality of T-Cell Epitopes App 20200016262 - Cobbold; Mark ;   et al. | 2020-01-16 |
Target Peptides For Cancer Therapy And Diagnostics App 20190374627 - Hunt; Donald F. ;   et al. | 2019-12-12 |
Chimeric Antigen Receptors Based On Alternative Signal I Domains App 20190330302 - MAUS; Marcela V. ;   et al. | 2019-10-31 |
Targeting moiety peptide epitope complexes having a plurality of T-cell epitopes Grant 10,441,649 - Cobbold , et al. Oc | 2019-10-15 |
Re-Directed Immunotherapy App 20190270779 - Cobbold; Mark ;   et al. | 2019-09-05 |
Re-directed immunotherapy Grant 10,287,321 - Cobbold , et al. | 2019-05-14 |
Identification Of Class I Mhc Associated Glycopeptides As Targets For Cancer Immunotherapy App 20190015494 - Hunt; Donald F. ;   et al. | 2019-01-17 |
Functional Antibody Fragment Complementation for a Two-Components System for Redirected Killing of Unwanted Cells App 20180346568 - COBBOLD; Mark | 2018-12-06 |
Immunotherapeutic molecules and uses Grant 10,106,621 - Cobbold , et al. October 23, 2 | 2018-10-23 |
Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells Grant 10,035,856 - Cobbold July 31, 2 | 2018-07-31 |
Immunotherapeutic Molecules And Uses App 20180105599 - COBBOLD; Mark ;   et al. | 2018-04-19 |
Class I Mhc Phosphopeptides For Cancer Immunotherapy And Diagnosis App 20180066017 - Hunt; Donald F. ;   et al. | 2018-03-08 |
Target Peptides For Immunotherapy And Diagnostics App 20170333541 - Hunt; Donald F. ;   et al. | 2017-11-23 |
Immunotherapeutic molecules and uses Grant 9,822,180 - Cobbold , et al. November 21, 2 | 2017-11-21 |
Functional Antibody Fragment Complementation For A Two-components System For Redirected Killing Of Unwanted Cells App 20170152316 - COBBOLD; Mark | 2017-06-01 |
Immunotherapeutic molecules and uses Grant 9,650,445 - Cobbold , et al. May 16, 2 | 2017-05-16 |
Target peptides for immunotherapy and diagnostics Grant 9,561,266 - Hunt , et al. February 7, 2 | 2017-02-07 |
Targeting Moiety Peptide Epitope Complexes Having A Plurality Of T-cell Epitopes App 20160220665 - Cobbold; Mark ;   et al. | 2016-08-04 |
Re-directed immunotherapy Grant 9,402,916 - Cobbold , et al. August 2, 2 | 2016-08-02 |
Immunotherapy App 20160206726 - Cobbold; Mark ;   et al. | 2016-07-21 |
Re-directed immunotherapy Grant 9,358,282 - Cobbold , et al. June 7, 2 | 2016-06-07 |
Re-Directed Immunotherapy App 20160106862 - Cobbold; Mark ;   et al. | 2016-04-21 |
Immunotherapeutic Molecules And Uses App 20160039942 - Cobbold; Mark ;   et al. | 2016-02-11 |
Target Peptides For Colorectal Cancer Therapy And Diagnostics App 20150328297 - Hunt; Donald F. ;   et al. | 2015-11-19 |
Agents and Methods App 20150297745 - Cobbold; Mark ;   et al. | 2015-10-22 |
Re-Directed Immunotherapy App 20150250868 - Cobbold; Mark ;   et al. | 2015-09-10 |
Target Peptides For Immunotherapy And Diagnostics App 20150224182 - Hunt; Donald F. ;   et al. | 2015-08-13 |
Immunotherapeutic Molecules And Uses App 20150183875 - Cobbold; Mark ;   et al. | 2015-07-02 |
Method And Apparatus For Enabling Commuter Groups App 20140172289 - Cobbold; Mark | 2014-06-19 |
Method and apparatus for enabling commuter groups Grant 8,660,781 - Cobbold February 25, 2 | 2014-02-25 |
Re-Directed Immunotherapy App 20140004081 - Cobbold; Mark ;   et al. | 2014-01-02 |
Class I Mhc Phosphopeptides For Cancer Immunotherapy And Diagnosis App 20130259883 - Hunt; Donald F. ;   et al. | 2013-10-03 |
Method And Apparatus For Enabling Commuter Groups App 20130179065 - Cobbold; Mark | 2013-07-11 |
Method and apparatus for enabling commuter groups Grant 8,340,890 - Cobbold December 25, 2 | 2012-12-25 |
Method and apparatus for enabling commuter groups Grant 8,150,608 - Cobbold April 3, 2 | 2012-04-03 |
Method And Apparatus For Enabling Commuter Groups App 20110246594 - Cobbold; Mark | 2011-10-06 |
Methods And Products For Measuring Free Immunoglobulin Light Chain Molecules App 20110229908 - Jefferis; Royston ;   et al. | 2011-09-22 |
Method and apparatus for enabling commuter groups Grant 7,974,771 - Cobbold July 5, 2 | 2011-07-05 |
Method and apparatus for enabling commuter groups App 20080077309 - Cobbold; Mark | 2008-03-27 |
Enhanced dual counter rotating ring network control system Grant 6,952,396 - Cottreau , et al. October 4, 2 | 2005-10-04 |
Virtual private networks and methods for their operation Grant 6,788,681 - Hurren , et al. September 7, 2 | 2004-09-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.